Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences

September 27, 2019 Posted by admin 0 thoughts on “Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences”

Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, Gruia AT, Tanasie G, Bunu C, Crisnic D, Gherghiceanu M, Tatu FR, Tatu CS, Vermesan S.
J Cell Mol Med. 2011;15(3):635-646. IF: 4.125;

Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1

September 27, 2019 Posted by admin 0 thoughts on “Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1”

Arnold LW, McCray SK, Tatu CA, Clarke SH.
J Immunol. 2000;164:2924-2930. IF: 5.362;

Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity

September 28, 2019 Posted by admin 0 thoughts on “Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity”

Tatu CA, Ye J, Arnold LW, Clarke SH
J Exp Med. 1999;190:903-914. IF: 13.912;

Betulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells

September 28, 2019 Posted by admin 0 thoughts on “Betulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells”

Soica C, Danciu C, Savoiu-Balint G, Borcan F, Ambrus R, Zupko I, Bojin F, Coricovac D, Ciurlea S, Avram S, Dehelean CA, Olariu T, Matusz P
Int J Mol Sci. 2014;15(5):8235-55. IF: 2.279;

Betulin complex in γ-cyclodextrin derivatives: properties and antineoplasic activities in in vitro and in vivo tumor models

September 28, 2019 Posted by admin 0 thoughts on “Betulin complex in γ-cyclodextrin derivatives: properties and antineoplasic activities in in vitro and in vivo tumor models”

Soica C, Dehelean C, Danciu C, Wang HM, Wenz G, Ambrus R, Bojin F, Anghel M
Int. J. Mol. Sci. 2012;13(11):14992-15011. IF: 2.279;

Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells

September 28, 2019 Posted by admin 0 thoughts on “Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells”

Cioca DP, Deak E, Cioca F, Paunescu V
J Immunother. 2006;29(1):41-52. IF: 4.508;

A characterization of four B16 murine melanoma cell sublines molecular fingerprint and proliferation behavior

September 28, 2019 Posted by admin 0 thoughts on “A characterization of four B16 murine melanoma cell sublines molecular fingerprint and proliferation behavior”

Danciu C, Falamas A, Dehelean C, Soica C, Radeke H, Barbu-Tudoran L, Bojin F, Pinzaru SC
Cancer Cell Int. 2013;13(1):75. IF: 1.989;

Improvement of ursolic and oleanolic acids’ antitumor activity by complexation with hydrophilic cyclodextrins

September 28, 2019 Posted by admin 0 thoughts on “Improvement of ursolic and oleanolic acids’ antitumor activity by complexation with hydrophilic cyclodextrins”

Oprean C, Mioc M, Csányi E, Ambrus R, Bojin F, Tatu C, Cristea M, Ivan A, Danciu C, Dehelean C, Paunescu V, Soica C
Biomed Pharmacother. 2016;83:1095-1104. IF: 2.326;

Bone marrow-derived cells in the tumor microenvironment contain cells with primitive hematopoietic phenotype

September 28, 2019 Posted by admin 0 thoughts on “Bone marrow-derived cells in the tumor microenvironment contain cells with primitive hematopoietic phenotype”

Deak E, Göttig S, Rüster B, Paunescu V, Seifried E, Gille J, Henschler R
Journal of Cellular and Molecular Medicine. 2010;14(7):1946-1952. IF: 4.608;

P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies

September 28, 2019 Posted by admin 0 thoughts on “P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies”

Tatu CA, Paunescu V, Stanescu DI, Schneider F
Anticancer Res. 1997;17(4A):2583-6. IF: 1.872;

Categories